Kindstar Globalgene Technology

SEHK:9960 Stock Report

Mkt Cap: HK$1.8b

Kindstar Globalgene Technology Future Growth

How is Kindstar Globalgene Technology forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


7.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

SEHK:9960 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20241,316125N/A6573
12/31/20231,136106N/A4223
12/31/20221,20999N/A5763
6/30/20221,152110-28734N/A
3/31/20221,041-672-25451N/A
12/31/2021931-1,454-22068N/A
9/30/2021915-1,919-9373N/A
6/30/2021900-2,3843478N/A
3/31/2021896-1,6794076N/A
12/31/2020891-9744773N/A
12/31/2019833-1705899N/A
12/31/2018706-53-754N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 9960's forecast earnings growth (7.9% per year) is above the savings rate (1.6%).

Earnings vs Market: 9960's earnings (7.9% per year) are forecast to grow slower than the Hong Kong market (16.5% per year).

High Growth Earnings: 9960's earnings are forecast to grow, but not significantly.

Revenue vs Market: 9960's revenue (4.3% per year) is forecast to grow slower than the Hong Kong market (9.6% per year).

High Growth Revenue: 9960's revenue (4.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 9960's Return on Equity is forecast to be low in 3 years time (3%).


Discover growth companies